Partial purification and some biochemical properties of neonatal rat cutaneous glutathione S-transferases by Kulkarni, Arun P. et al.
Comp. Biochem. Physiol. Vol. 87B, No. 4, pp. 1005-1009, 1987 0305-0491/87 $3.00 + 0.00 
Printed in Great Britain © 1987 Pergamon Journals Ltd 
PARTIAL PURIFICATION AND SOME BIOCHEMICAL 
PROPERTIES OF NEONATAL RAT CUTANEOUS 
GLUTATHIONE S-TRANSFERASES 
ARUN P. KULKARNI*, JOHN L. NELSON and Louis L. RADULOVIC 
Toxicology Program, Department of Environmental and Industrial Health, School of Public Health, The 
University of Michigan, Ann Arbor, MI 48109-2029, USA 
(Received 8 September 1986) 
Abstract--1. Previous studies have demonstrated the presence of glutathione S-transferases in the skin of 
rodents and humans. This study represents the first attempt to purify cytosolic glutathione S-transferases 
from skin of 3-day-old rats. 
2. A partial purification of the enzyme was achieved by a two-step procedure: affinity chromatography 
followed by HPLC. Two peaks, one major (P-l) and one minor (P-2), were resolved by HPLC containing 
about 82% and 10% of the recovered activity, respectively. 
3. The major form exhibited an overall purification of about 2270-fold with a specific activity of about 
73 #moles/min/mg protein towards 1-chloro-2,4-dinitrobenzene. 
4. The kinetic data for P-I yielded mean Km values of 2.39 mM for 1-chloro-2,4-dinitrobenzene and 
0.72 mM for reduced glutathione, while the respective average Vma x values were found to be 212 and 
101/~moles/min/mg protein. 
5. Significantly inhibition of enzyme activity was noted in the presence of 0.2 mM HgCI 2, 0.63 pM 
1.2-naphthoquinone, 1.0 #M triphenyltin chloride, and 12.5 #M 17fl-estradiol-3-sulfate. 
INTRODUCTION 
G S H T r  (EC2.5.1.18) represent a family of  highly 
versatile enzymes which are active in catalyzing the 
conjugation of  GSH with a large number of  endo- 
genous and exogenous chemicals bearing an electro- 
philic center (Chasseaud, 1979; Jakoby and Habig, 
1980). G S H T r  occur in multiple forms in most tissues 
and several reports on the purification and character- 
ization of  G S H T r  isozymes from major  organs are 
available (Jakoby and Habig, 1980; Mannervik,  
1985). In contrast to this, very little is known about  
G S H T r  from skin. Earlier reports have shown the 
presence of  G S H T r  activity in rodent skin cells grown 
in culture (Coomes et al., 1983; Kawashima et al., 
1984) and in skin cytosol (Hayakawa et al., 1974; 
Mukhtar  and Bresnick, 1976; Mukhtar  and Bickers, 
1981, 1983; Mukhtar  et al., 1981a). Human  skin has 
also been shown to possess G S H T r  activity (Mukhtar  
and Bresnick, 1976; Mukhtar  et al., 1981b). A brief 
report based on qualitative immunochemical  analysis 
suggested the presence of  multiple forms of  cutaneous 
G S H T r  in adult rat (Redick et al., 1982). It is 
noteworthy that all the previous studies were per- 
formed with crude preparations of  cutaneous 
GSHTr .  In this communication,  we report for the 
first time the isolation and partial purification of  two 
groups of  G S H T r  from skin cytosol of  neonatal  rats 
using affinity chromatography and H P L C  and some 
biochemical properties of  the major  form. 
*To whom correspondence should be addressed. 
Abbreviations: CDNB, 1-chloro-2,4-dinitrobenzene; GSH, 
reduced glutathione; DTT, dithiothreitol; HPLC, 
high performance liquid chromatography; GSHTr, 
glutathione S-transferase(s). 
MATERIALS AND METHODS 
Materials 
CDNB and 1,2-naphthoquinone were purchased from 
Aldrich Co., Wisconsin, USA. GSH and DTT were ob- 
tained from U.S. Biochemical Co. The Sepharose 4B, and 
17/~-estradiol-3-sulfate were the products of Sigma Chem- 
ical Co. Triphenyltin chloride was from Alfa Products, 
USA. 
Animals 
Three day old neonates of inbred CFN rats were used. 
Enzyme isolation 
Rats were killed by cervical dislocation. The skins were 
removed and immediately placed in ice-cold 50 mM Tris- 
HC1 buffer, pH 7.2 containing 0.25 M sucrose (Buffer-A). 
Each skin was spread epidermal side down on a petridish 
and the dermis was cleared of fat and muscle by careful 
scraping with a blunt scalpel. The skins (from 25-30 
rats/preparation) were weighed, minced and homogenized 
in ice-cold buffer-A (20% homogenate, w/v) using an Ultra- 
Turrax tissue homogenizer (six 20 sec bursts with 40 sec 
intervals for cooling). The homogenates were sonicated for 
10 sec, rehomogenized in a glass-Teflon homogenizer, and 
centrifuged at 39,000g for 30 min at 4°C. the supernatant 
(cytosol) was carefully decanted and used as the enzyme 
source. 
Affinity chromatography 
In a typical experiment, cytosol containing about 7 U of 
GSHTr was applied to the column (2.8 × 6.0 cm) of GSH 
coupled epoxy-activated Sepharose4B, which was pre- 
equilibrated with 50 mM Tris-HCl buffer, pH 7.4 at 4°C. 
The affinity chromatography of cutaneous GSHTr was 
conducted as described previously (Radulovic and 
Kulkarni, 1985). 
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High performance liquid chromatography 
HPLC was performed as described previously (Radulovic 
and Kulkarni, 1985) with some modifications. The mobile 
phase consisted of 10mM potassium phosphate buffer 
containing 1.0mM DTT and 10mM GSH, pH7.2 
(buffer-B), and buffer-C containing 0.4 M KC1 in buffer-B. 
Prior to HPLC, the eluate from the affinity column was 
concentrated by ultrafiltration using PM-10 membrane, and 
dialyzed overnight against buffer-B. An aliquot (0.5-1.0 ml) 
was injected onto the anion exchange column (Synchrom 
AX-300 from Synchrom, Linden, IN, USA) and eluted with 
salt gradient. The program used was as follows: Flow rate 
of 1.0ml/min and % buffer-C=0 at time ( t ) = 0 ;  % 
buffer-C was increased to 7.5 in 3min, beginning at 
t = 5 min; % buffer-C was further increased to 100 in 5 min 
at t = 8 min; re-equilibration began at t = 21 min, at which 
time % buffer-C was decreased to 0 over 2 min and the flow 
was maintained at 2.0ml/min for 15min. The HPLC 
effluent was collected in 1.0 ml fractions and assayed for 
GSHTr activity. Those fractions exhibiting GSHTr activity 
peaks were combined. 
Enzyme assay 
GSHTr activity toward CDNB was determined at 37°C 
using an Amino DW-2, as described previously (Radulovic 
and Kulkarni, 1985). Duplicate assays were performed with 
a rate-limiting enzyme concentration. One enzyme unit is 
defined as the amount of enzyme that causes formation of 
1.0/~mole of CDNB-conjugate/min/mg protein. In kinetic 
and inhibition experiments, the pooled fractions from P-I 
peak were concentrated by ultrafiltration using PM-10 
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membrane and dialyzed against I0 mM potassium phos- 
phate buffer, pH 7.2 containing 0.1 mM GSH before use. 
Inhibitors were incubated with the enzyme in buffer for 
3 min at 37°C, prior to the addition of GSH and CDNB. 
Mercuric chloride was dissolved in deionized water. All 
other inhibitors were dissolved in 95% ethanol. The re- 
ported data are corrected for solvent effects. 
Protein content of the cytosol was determined by the 
method of Lowry et al. (1951), while the dye binding assay 
of Bradford (1976) was utilized in subsequent purification 
steps. 
RESULTS 
Table  1 summarizes  the results of  the experiments  
on  the purif icat ion of  G S H T r  f rom skin cytosol of  
3-day-old rats using the two-step procedure.  G S H T r  
adsorbed  on  the affinity mat r ix  eluted as a single peak 
(not  shown) with an  average recovery of  abou t  85%. 
The  affinity ch rom a t og r aphy  step alone resulted in a 
615-fold purif ication of  the enzyme. The G S H T r  
isozymes present  in the 4B-GSH concent ra te  were 
resolved into 2 peaks of  activity by HPLC.  The 
ch romatograph ic  profile of  G S H T r  elut ion f rom the 
H P L C  co lumn observed in a typical exper iment  is 
depicted in Fig. 1. The recovery of  G S H T r  activity 
dur ing  H P L C  step was abou t  82%. Approximate ly  
80% of  the total  recovered G S H T r  activity was 
present  in the ma jo r  peak (P-l) ,  with a re tent ion time 
of  4.8 min. This peak emerged f rom the co lumn just  
after the void volume and  before the salt gradient.  
The observed average specific activity of  73 #moles  of  
CDNB-con juga te  fo rmed /min /mg  prote in  for P-1 
corresponds  to an  overall  purif ication of  2271-fold 
(Table 1). The minor  peak (P-2) represented abou t  
10%o of  the recovered activity, with a re tent ion time 
of  abou t  14 min. The remaining 10%o of  the recovered 
activity was dis t r ibuted in low amounts  on the frac- 
t ions which did not  const i tute  P-1 and  P-2. 
Three  separate  enzyme prepara t ions  were used to 
evaluate the kinetic parameters  of  the cu taneous  
GSHTr .  The G S H  concen t ra t ion  was kept  cons tan t  
at  2.5 m M  for the de te rmina t ion  of  Km and Vmax for 
C D N B ;  while 1.0 m M  C D N B  was employed for the 
evaluat ion of  the same parameters  for GSH.  The 
est imated values for the kinetic parameters  examined 
are presented in Table  2. Representat ive 
L ineweaver -Burk  plots of  the kinetic data  (Sample 3, 
Table  2) are shown in Figs 2 and  3. Approximate ly  
2-fold var ia t ion  in the K,, and  up to 5-fold var ia t ion  
in the Vma X values was no ted  with the enzyme prepa-  
rat ions used. 
Fig. 1. HPLC chromatographic profile of GSHTr. Chro- 
matography was performed as described in Materials and 
Methods. Protein content was monitored at 280 nm ( ). 
Specific activity of GSHTr ( . . . . .  ) is expressed in nmoles of 
CDNB-conjugate formed/min/ml effluent. All fractions con- 
tained a 1.0 ml volume. 
Table 1. Partial purification of the neonatal rat cutaneous GSHTr 
Specific activity* Recovery 
Fraction ( /zmoles /min/mg)  Purification (%) 
Supernatant 0.032 +_ 0.002 1 100 
4B-GSH 19.690 + 4.024 615 85 
HPLC 72.667 +_ 14.769 2271 65 
*Values reported are mean _+ SE. (n = 3). 
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Table 2. Kinetic parameters of partially purified rat neonate skin 
GSHTr from HPLC P-1 Fraction 
CDNB GSH 
Sample Number K* Vtm~, K* V~m.x 
1 1.98 88.25 0.59 55.00 
2 3.69 433.00 0.56 132.00 
3 1.50 116.00 1.01 115.00 
M e a n  2.39 212.42 0.72 100.67 
_ S E  0.67 110.58 0.15 23.35 
*Expressed as mM concentrations. 
tExpressed as/~mole CDNB-conjugate formed/min/mg protein. 
Experiments were also performed in which the 
relative ability of selected inhibitors to inactivate 
cutaneous GSHTr was examined. Several pilot ex- 
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concentration that could produce approx. 50% in- 
hibition of the GSHTr activity. Due to a limited 
availability of the partially purified enzyme, detailed 
analyses were not possible. GSHTr present in only 
the P-I fractions obtained after HPLC were used in 
these studies. Among the compounds tested, triph- 
enyltin chloride and 1,2-naphthoquinone were found 
to be potent inhibitors of the enzyme. The % in- 
hibition (mean + SE, n = 3) of GSHTr activity ob- 
served in the presence of different inhibitors was as 
follows: 67.1 + 3.2 with 200#M HgC12; 58.1 + 9.2 
with 1.0/tM triphenyltin chloride; 55.9 + 6.3 with 
0.63 #M 1,2-naphthoquinone; and 42.8 _ l l .5  with 
12.5/~M 17-fl-estradiol-3-sulfate. Specific activity in 
the controls ranged from 21.4 to 72.0 ttmoles CDNB- 
conjugate formed/min/mg protein. Under the experi- 
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Fig. 2. Lineweaver-Burk plot of  cutaneous glutathione S-transferase showing the effect of  C D N B  
concentration on initial velocity. Assays were performed as described in Materials and Methods. 
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Fig. 3. Lineweaver-Burk plot of  cutaneous glutathione S-transferase showing the effect of  reduced 
glutathione concentration on intial velocity. Assays were performed as described in Materials and 
Methods. 
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mental conditions employed, all the chemical tested 
caused significant inhibition (p =0.05), as deter- 
mined statistically by paired-t analysis. 
DISCUSSION 
Irrespective of the tissue source, overlapping sub- 
strate specificity is a known qualitative property of all 
the isozymes of GSHTr studied thus far. Quan- 
titatively however, marked differences in substrate 
specificity between GSHTr isozymes do exist in 
different mammalian tissues (Chasseaud, 1979; 
Jakoby and Habig, 1980; Mannervik, 1985). CDNB 
has been most commonly used to measure tissue 
GSHTr titers since it serves as a substrate for all the 
known isozymes of GSHTr (Jakoby and Habig, 1980; 
Mannervik, 1985). In view of this, the previously 
reported data based on arene oxides as substrates 
(Mukhtar and Bresnick, 1976; Mukhtar and Bickers, 
1981, 1983; Mukhtar et al., 1981a) possibly reflect on 
a partial quantitation of GSHTr activity in the 
cytosolic fractions of neonatal rat skin. This is the 
first communication reporting the GSHTr activity 
towards CDNB in the cytosol isolated from neonatal 
rat skin (Table 1). 
Although affinity chromatography yielded sub- 
stantial purification of cutaneous GSHTr (Table 1), 
the observed recovery of enzyme in this step (about 
85%) is much lower than that reported for the human 
placental GSHTr (Radulovic and Kulkarni, 1985) 
and this may not be related to the denaturation of the 
enzyme during chromatography. We believe that the 
observed incomplete recovery of rat cutaneous 
GSHTr may be due to the loss of certain isozyme(s) 
of GSHTr that are not bound to the affinity matrix 
used. It should be noted that this is not a unique 
property of the cutaneous GSHTr, since similar 
results, for at least one form (isozyme 5-5) of rat liver 
GSHTr, have previously been reported (Robertson et 
al., 1985). 
Similar to the procedure for purification of human 
placental GSHTr (Radulovic and Kulkarni, 1985), 
HPLC was found to be a rapid, and effective method 
of purification of the cutaneous GSHTr. It was 
possible to resolve the mixture of GSHTr isozymes, 
isolated by the affinity chromatography, into at least 
two groups. The chromatographic behaviour sug- 
gests that the GSHTrs present in P-2 stongly interact 
with the column matrix and may be anionic in nature. 
By the same token, the apparent minimal interaction 
with the column matrix noted with the GSHTr eluted 
in P-1 is indicative of either a basic or neutral nature. 
In the GSHTr activity profiile (Fig. 1), a splitting of 
the P-I peak was observed in all the samples ana- 
lyzed. This suggests that more than one isozyme of 
GSHTr may be present in P-I. The kinetic data 
(Table 2) exhibited a wide variation in the results 
obtained with different enzyme preparations used and 
this variation, in part, may be due to differences in the 
ratios of different isozymes present in the P-1 frac- 
tion. The K,~ and Vma x values (Table 2) and inhibition 
data for cutaneous GSHTr are, however, within the 
range reported for purified GSHTr isozymes from 
several other tissues (Henry and Byington, 1976; Ohl 
and Litwack, 1977; Kulkarni et al., 1978; Dierickx, 
1982; Mannervik, 1985). In summary, the results 
indicate that multiple forms of GSHTr exist in the 
skin cytosol on neonate rats. Although this con- 
tention is further supported by an earlier report 
demonstrating the presence of isozyme B, C and E in 
adult rat skin by an immunohistochemical technique 
(Redick et al., 1982), further studies are needed to 
clearly resolve this issue. 
SUMMARY 
Affinity chromatography and HPLC were em- 
ployed to evaluate the multiplicity of GSHTr in the 
skin cytosol from 3-day-old rats of CFN strain. The 
mixture of GSHTr isozymes was resolved into two 
groups. The major group (isolated as P-I peak by 
HPLC) represents about 80% of the recovered 
GSHTr activity and appears to be a composite of 
neutral and/or basic proteins. Kinetic parameters and 
relative inhibition by the selected chemicals of P-1 
GSHTr were evalutated. Strongly anionic form(s) of 
GSHTr (P-2) also occur in the skin cytosol but in 
small amounts. Although the number of isozymes 
present was not determined, the results, in general, 
suggest multiplicity of GSHTr in the neonatal rat 
skin. 
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